IVE vs PRWCX: 13% overlap
iShares S&P 500 Value ETF and T. Rowe Price Capital Appreciation share 13.1% of their portfolios by weight — computed as Σ min(wA, wB) over every holding both funds own.
Different holding dates. These holdings were published about 4 months apart — PRWCX as of 2026-03-31, the rest through 2026-07-23. Each fund is compared using its most recent file, so any trading in between shows up as a difference.
You would hold two tickers and get the diversification of 1.9. Two funds that shared nothing would score 2.0; two identical funds score 1.0.
Top shared holdings
IVE and PRWCX hold 27 of the same securities. The ten contributing most to the overlap figure:
| Holding | in IVE | in PRWCX | Δ |
|---|---|---|---|
| AMZN | 3.7% | 4.8% | 1.1% |
| AAPL | 8.1% | 3.6% | 4.5% |
| UNH | 1.3% | 0.8% | 0.5% |
| JPM | 1.0% | 0.7% | 0.3% |
| V | 0.9% | 0.7% | 0.2% |
| MA | 0.5% | 0.9% | 0.5% |
| DHR | 0.4% | 0.7% | 0.3% |
| SBUX | 0.4% | 1.1% | 0.7% |
| SLB | 0.2% | 0.3% | 0.0% |
| CVX | 1.2% | 0.2% | 1.0% |
Where IVE and PRWCX differ
Sector weights as a share of each fund, ordered by the size of the gap rather than the size of the sector — two funds that overlap heavily still usually diverge somewhere.
| Sector | IVE | PRWCX | Δ |
|---|---|---|---|
| Unclassified | 0.0% | 20.3% | −20.3pp |
| Treasuries | 0.0% | 18.2% | −18.2pp |
| Financials | 16.1% | 2.4% | +13.7pp |
| Industrials | 11.5% | 0.9% | +10.6pp |
| Consumer Staples | 8.7% | 0.6% | +8.0pp |
| Energy | 7.4% | 0.7% | +6.7pp |
| Cash & Other | -0.0% | 5.0% | −5.1pp |
| Communication Services | 2.9% | 6.7% | −3.8pp |
Δ is IVE minus PRWCX, in percentage points. Sector data is not published by every issuer, so “Unclassified” is a real category rather than a gap in the table.
What each fund holds alone
79.1% of IVE by weight, held in no part of PRWCX.
64.8% of PRWCX by weight, held in no part of IVE.
A large count with a small weight is the usual shape: the positions one fund adds are typically its smallest ones.
Concentration and cost
| IVE | PRWCX | |
|---|---|---|
| Top 10 holdings | 23.7% | 46.0% |
| Positions held | 440 | 151 |
| Cost per $10,000 held, per year | $18 | $72 |
Cost is the expense ratio applied to $10,000; it excludes any brokerage commission, bid-ask spread or tax consequence. Figures are facts about the funds, not a suggestion about which to hold.
Frequently asked
How much do IVE and PRWCX overlap?
IVE and PRWCX overlap 13.1% by portfolio weight — largely distinct portfolios. They share 27 holdings. The figure comes from current issuer holdings files (IVE as of 2026-07-23, PRWCX as of 2026-03-31).
How is the overlap between IVE and PRWCX calculated?
As the sum of the smaller weight in each fund, over every holding both funds own: Σ min(wA, wB). If IVE holds a stock at 6% and PRWCX holds the same stock at 4%, 4% counts as shared. The result is bounded between 0% and 100%, and it is computed after looking through any fund-of-funds to the underlying holdings.
Is it redundant to hold both IVE and PRWCX?
That depends on your goals — we state facts, not advice. At 13.1% overlap, each fund still contributes meaningfully distinct exposure.
What does IVE own that PRWCX doesn't?
IVE holds 440 positions and PRWCX holds 151; 412 of IVE's positions don't appear in PRWCX at all, and they are 79.1% of IVE by weight.
You probably hold more than two funds
This page compares IVE and PRWCX. Paste your whole portfolio — brokerage, 401(k), IRA — and see the overlap across every fund at once, plus what you actually own underneath them and your own Effective Funds number. Free, no account, nothing stored.
X-ray my portfolio — free →Watch IVE vs PRWCX
We re-read both funds’ published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.
Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.
Related comparisons
Sources: issuer holdings files, IVE as of 2026-07-23, PRWCX as of 2026-03-31. Weights are fractions of each fund. Diagnostics, not advice.